Clinical Efficacy and Risks of Intradiscal Orthobiological Injections: A Narrative Review
- 01-12-2025
- Back Pain
- Alternative Treatments for Pain Medicine (C Robinson, Section Editor)
- Authors
- Macie A. Serio
- Rachael Bartolina
- Sanjana Sudini
- Ellie M. MacDonald
- Austin S. Thomassen
- Sahar Shekoohi
- Azem A. Chami
- Alan D. Kaye
- Published in
- Current Pain and Headache Reports | Issue 1/2025
Abstract
Purpose of Review
Chronic discogenic low back pain (LBP) is a common cause of disability worldwide. Current management options include conservative, surgical, and minimally invasive interventional injections. Intradiscal orthobiological injections of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and mesenchymal stem cells (MSCs) have been introduced as regenerative treatment options.
Recent Findings
Many studies have demonstrated improvements in patients' reported outcomes (PROMs) measuring the areas of pain, disability, function, and satisfaction. The results are promising with statistical improvements shown throughout various studies. Adverse events such as increased pain and infection have been reported with these injections; however, the complication rate has yet to be delineated.
Summary
Numerous studies report no adverse events in their sample size. The present investigation summarizes recent evidence for the efficacy and risks of PRP, BMAC, and MSC injections.
Advertisement
- Title
- Clinical Efficacy and Risks of Intradiscal Orthobiological Injections: A Narrative Review
- Authors
-
Macie A. Serio
Rachael Bartolina
Sanjana Sudini
Ellie M. MacDonald
Austin S. Thomassen
Sahar Shekoohi
Azem A. Chami
Alan D. Kaye
- Publication date
- 01-12-2025
- Publisher
- Springer US
- Published in
-
Current Pain and Headache Reports / Issue 1/2025
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081 - DOI
- https://doi.org/10.1007/s11916-025-01414-y
This content is only visible if you are logged in and have the appropriate permissions.